ArticleFrontiers in neurology2023

Examination of betahistine bioavailability in combination with the monoamine oxidase B inhibitor, selegiline, in humans-a non-randomized, single-sequence, two-period titration, open label single-center phase 1 study (PK-BeST).

Michael Strupp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.